Europe Scar Treatment Market | Global Research Report, 2013-2023
Europe scar treatment market © Rahul Gautam
The Europe scar treatment market size was valued at $5.2 billion in 2016, which is expected to reach $9.8 billion by 2023, growing at a CAGR of 9.6% during the forecast period (2017-2023).
Topical scar treatment is expected to witness highest growth during the forecast period in the European scar treatment market due to increasing disposable income, rising prevalence of chronic wounds and availability of different types of topical scar treatment products. Topical scar treatment is followed by surface scar treatment, laser scar treatment, injectable scar treatment, invasive surgical scar treatment.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/europe-scar-treatment-market/report-sample
The technological advancements and rising awareness about skin related problems and their available treatments are also key factors leading to the growth of the European scar treatment market. For instance, in February 2017, Lumenis Ltd. supported International Scar Treatment Conference in Israel, held in Tel Aviv, focused on spreading awareness about the interdisciplinary approach for successful management of scars. According to the European Wound Management Association (EWMA), around 4 million wound cases are reported every year in the Europe. This in turn, is driving the demand for scar treatment products in the region. Furthermore, according to the OECD, the German household disposable income was $34,887.8 in 2014, compared to $34,286.2 in 2013.
Explore Full Report Description At@
https://www.psmarketresearch.com/market-analysis/europe-scar-treatment-market
Some of the key players operating in the European scar treatment market include Merz GmbH & Company KGAA, Mölnlycke Health Care AB, Smith & Nephew Plc, Syneron Medical Ltd., Lumenis Ltd., L'oreal S.A, H&R Healthcare Ltd., Avita Medical, Arbonne International, and Laverana GmbH & Co.KG.
Topical scar treatment is expected to witness highest growth during the forecast period in the European scar treatment market due to increasing disposable income, rising prevalence of chronic wounds and availability of different types of topical scar treatment products. Topical scar treatment is followed by surface scar treatment, laser scar treatment, injectable scar treatment, invasive surgical scar treatment.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/europe-scar-treatment-market/report-sample
The technological advancements and rising awareness about skin related problems and their available treatments are also key factors leading to the growth of the European scar treatment market. For instance, in February 2017, Lumenis Ltd. supported International Scar Treatment Conference in Israel, held in Tel Aviv, focused on spreading awareness about the interdisciplinary approach for successful management of scars. According to the European Wound Management Association (EWMA), around 4 million wound cases are reported every year in the Europe. This in turn, is driving the demand for scar treatment products in the region. Furthermore, according to the OECD, the German household disposable income was $34,887.8 in 2014, compared to $34,286.2 in 2013.
Explore Full Report Description At@
https://www.psmarketresearch.com/market-analysis/europe-scar-treatment-market
Some of the key players operating in the European scar treatment market include Merz GmbH & Company KGAA, Mölnlycke Health Care AB, Smith & Nephew Plc, Syneron Medical Ltd., Lumenis Ltd., L'oreal S.A, H&R Healthcare Ltd., Avita Medical, Arbonne International, and Laverana GmbH & Co.KG.